B+
Bull case
25%
Probability
Target price
$7.35
Analysis reference price unavailable
Analysis 2026-03-26 · RankAlpha Sentiment AI
ABUS
Arbutus BiopharmaBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive readouts/cost reductions or a value-accretive partnership/financing at favorable terms could re-rate shares toward higher analyst highs and specialist takeover/partner interest, supporting the bull target.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +1.0.
What can break
Clinical/program delays or negative data
Momentum
66
Value
56
Sentiment
69
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.68 · Bull $7.35 · Bear $3.00Analysis 2026-03-26; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-03-26 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $5.50
Why
Momentum66 · Δ7d -15.4
Value56 · Δ7d -0.0
Sentiment69 · Δ7d +1.0
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +1.0.
Contradictions & invalidation
- • Clinical/program delays or negative data
- • Dilutive financing at unfavorable terms
- • Delay in program progress, larger-than-expected cash burn, or a dilutive financing at unfavorable terms would push valuation below current levels toward the bear target.
Catalyst clock
2026-06-24
Next quarterly results / corporate update (Q1 2026)
Lead driver: Sentiment · See AI snapshot
Momentum
66
9% active weight
Current posture
7d trendSoftening
Δ7d
-15.4
Δ21d
+26.1
Value
56
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+15.2
Sentiment
69
62% active weight
Current posture
7d trendImproving
Δ7d
+1.0
Δ21d
-6.5
Why this grade
Composite grade B. Momentum 65.9 / Value 56.3 / Sentiment 69.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-03-26. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$5.68
Analysis reference price unavailable
Analysis 2026-03-26 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$3.00
Analysis reference price unavailable
Analysis 2026-03-26 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$931.86M
Beta
0.72
Shares Out
197.85M
P/E (TTM) · Derived
-26.9
P/S (TTM)
62.02
P/FCF (TTM) · Derived
-22.73
Rev YoY
-90.6%
EPS YoY
-298.5%
Gross Margin
+100.0%
Op Margin
+81.1%
Net Debt
-$87.28M
Current Ratio
81.42
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data